Published in PLoS One on April 02, 2014
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies. J Cancer (2016) 0.93
Advances in β cell replacement and regeneration strategies for treating diabetes. J Clin Invest (2016) 0.82
Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells. Diabetes (2016) 0.81
Integrating Diverse Types of Genomic Data to Identify Genes that Underlie Adverse Pregnancy Phenotypes. PLoS One (2015) 0.75
β-Cell adaptation in pregnancy. Diabetes Obes Metab (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res (1998) 5.41
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature (1996) 5.40
Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science (2007) 3.55
ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol (2004) 3.18
Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med (2010) 2.98
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology (2008) 2.59
Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology (1992) 2.52
Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res (1997) 2.46
Tomographic molecular imaging and 3D quantification within adult mouse organs. Nat Methods (2006) 2.23
The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol (2009) 1.89
Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem (2006) 1.83
Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab (2009) 1.81
Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology (1995) 1.52
Quantification and three-dimensional imaging of the insulitis-induced destruction of beta-cells in murine type 1 diabetes. Diabetes (2010) 1.50
Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen. Diabetes (2009) 1.47
Targeting survivin in cancer: the cell-signalling perspective. Drug Discov Today (2011) 1.40
Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes (2006) 1.33
Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology (2003) 1.28
Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia (2010) 1.28
Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. Diabetes (2001) 1.27
ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture. Endocrinology (2002) 1.19
EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway. Exp Mol Pathol (2005) 1.09
Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene (2006) 1.03
Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes (2008) 0.99
Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation. Diabetologia (2011) 0.98
Non-β-cell progenitors of β-cells in pregnant mice. Organogenesis (2010) 0.94
Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice. EMBO Rep (2006) 0.92
Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1. Diabetes (2013) 0.91
An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans. J Histochem Cytochem (2002) 0.90
Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway. Horm Metab Res (2003) 0.90
EGF-induced proliferation of adult human pancreatic duct cells is mediated by the MEK/ERK cascade. Lab Invest (2005) 0.89
mRNA expression analysis of cell cycle genes in islets of pregnant mice. Diabetologia (2010) 0.88
Perinatal survivin is essential for the establishment of pancreatic beta cell mass in mice. Diabetologia (2009) 0.87
Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology (1997) 0.82
Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling. J Mammary Gland Biol Neoplasia (2008) 0.81
In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes. Diabetologia (2014) 0.79
Epidermal growth factor induces adult human islet cell dedifferentiation. J Endocrinol (2011) 0.78
Survivin is required for beta-cell mass expansion in the pancreatic duct-ligated mouse model. PLoS One (2012) 0.78